Sponsor:
Boston Children's Hospital
Code:
NCT04712812
Conditions
Hereditary Spastic Paraplegia
SPG47
SPG50
SPG51
SPG52
Eligibility Criteria
Sex: All
Age: 0 - 30
Healthy Volunteers: Accepted
Brief summary:
Conditions
Hereditary Spastic Paraplegia
SPG47
SPG50
SPG51
SPG52
Study ID
NCT04712812
Start date
Apr 27, 2020
Status verified date
Mar, 2026
Completion date
Dec 31, 2030
Anticipated
Primary completion date
Dec 31, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 30
Healthy Volunteers: Accepted
Enrollment
700 participants
Anticipated
Arms
Proband with Hereditary Spastic Paraplegia
Primary outcome measure
Central contacts
Nicole Battaglia, BS
hsp.research@childrens.harvard.eduLocations
Boston Children's Hospital
Recruiting
Boston, Massachusetts, United States, 02115
Contacts
Nicole Battaglia, BS
hsp.research@childrens.harvard.eduPrincipal Investigator:
Darius Ebrahimi-Fakhari, MD, PhD
Sponsor
Boston Children's Hospital
Last update posted
Mar 18, 2026
Last verified
Mar, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston Children's Hospital on 2026-03-18.